Influenza coverages in Spain and vaccination-related factors in the subgroup aged 50-64 years.
Identifieur interne : 000642 ( Main/Exploration ); précédent : 000641; suivant : 000643Influenza coverages in Spain and vaccination-related factors in the subgroup aged 50-64 years.
Auteurs : Rodrigo Jiménez [Espagne] ; Amparo Larrauri ; Pilar Carrasco ; Jesús Esteban ; Luis Ignacio G Mez-L Pez ; Angel GilSource :
- Vaccine [ 0264-410X ] ; 2003.
Descripteurs français
- KwdFr :
- Adolescent (MeSH), Adulte (MeSH), Adulte d'âge moyen (MeSH), Analyse de variance (MeSH), Espagne (épidémiologie), Facteurs socioéconomiques (MeSH), Facteurs âges (MeSH), Femelle (MeSH), Grippe humaine (complications), Grippe humaine (prévention et contrôle), Grippe humaine (épidémiologie), Humains (MeSH), Mode de vie (MeSH), Mâle (MeSH), Odds ratio (MeSH), Vaccination (statistiques et données numériques), État de santé (MeSH), Études transversales (MeSH).
- MESH :
- prévention et contrôle : Grippe humaine.
- statistiques et données numériques : Vaccination.
- épidémiologie : Espagne, Grippe humaine.
- Adolescent, Adulte, Adulte d'âge moyen, Analyse de variance, Facteurs socioéconomiques, Facteurs âges, Femelle, Humains, Mode de vie, Mâle, Odds ratio, État de santé, Études transversales.
- Wicri :
- geographic : Espagne.
English descriptors
- KwdEn :
- Adolescent (MeSH), Adult (MeSH), Age Factors (MeSH), Analysis of Variance (MeSH), Cross-Sectional Studies (MeSH), Female (MeSH), Health Status (MeSH), Humans (MeSH), Influenza, Human (complications), Influenza, Human (epidemiology), Influenza, Human (prevention & control), Life Style (MeSH), Male (MeSH), Middle Aged (MeSH), Odds Ratio (MeSH), Socioeconomic Factors (MeSH), Spain (epidemiology), Vaccination (statistics & numerical data).
- MESH :
- geographic , epidemiology : Spain.
- complications : Influenza, Human.
- epidemiology : Influenza, Human.
- prevention & control : Influenza, Human.
- statistics & numerical data : Vaccination.
- Adolescent, Adult, Age Factors, Analysis of Variance, Cross-Sectional Studies, Female, Health Status, Humans, Life Style, Male, Middle Aged, Odds Ratio, Socioeconomic Factors.
Abstract
This study sought to describe influenza vaccination coverages for different Spanish population subgroups, stressing the analysis of vaccination-related factors in subjects aged 50-64 years and estimating the possible beneficial effect of extending universal vaccination to this age group. A total of 6,400 surveys, targeting subjects over the age of 16 years and drawn from the 1997 Spanish National Health Survey, were used for study purposes. Influenza coverage was observed to rise significantly with age, and the reason cited by most subjects for seeking vaccination was medical indication. Coverage of the 50-64 age group was 21.6% (95% CI 19.4-23.8) and the variables associated with a greater probability of being vaccination were: residence in towns or cities with <10,000 inhabitants (OR 1.45); monthly income of less than 600 (OR 1.71); and presence of associated chronic disease (OR 3.07.) It is estimated that in Spain, 524,514 (40.7%) persons aged 50-64 years with associated chronic disease receive and 764,218 persons aged 50-64 years with associated chronic disease do not receive influenza vaccine. We conclude that the extremely high number of subjects in the 50-64 age range susceptible to influenza-related complications each year constitutes good grounds for universal vaccination being extended to said age group.
DOI: 10.1016/s0264-410x(03)00425-0
PubMed: 12922082
Affiliations:
Links toward previous steps (curation, corpus...)
Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Influenza coverages in Spain and vaccination-related factors in the subgroup aged 50-64 years.</title><author><name sortKey="Jimenez, Rodrigo" sort="Jimenez, Rodrigo" uniqKey="Jimenez R" first="Rodrigo" last="Jiménez">Rodrigo Jiménez</name><affiliation wicri:level="2"><nlm:affiliation>Unidad de Docencia e Investigación en Medicina Preventiva y Salud Pública, Facultad de Ciencias de la Salud, Universidad Rey Juan Carlos, Avenida de Atenas S/N, Alcorcón, 28402 Madrid, Spain. rjimenezg@cs.urjc.es</nlm:affiliation><country xml:lang="fr">Espagne</country><wicri:regionArea>Unidad de Docencia e Investigación en Medicina Preventiva y Salud Pública, Facultad de Ciencias de la Salud, Universidad Rey Juan Carlos, Avenida de Atenas S/N, Alcorcón, 28402 Madrid</wicri:regionArea><placeName><region nuts="2" type="communauté">Communauté de Madrid</region></placeName></affiliation></author><author><name sortKey="Larrauri, Amparo" sort="Larrauri, Amparo" uniqKey="Larrauri A" first="Amparo" last="Larrauri">Amparo Larrauri</name></author><author><name sortKey="Carrasco, Pilar" sort="Carrasco, Pilar" uniqKey="Carrasco P" first="Pilar" last="Carrasco">Pilar Carrasco</name></author><author><name sortKey="Esteban, Jesus" sort="Esteban, Jesus" uniqKey="Esteban J" first="Jesús" last="Esteban">Jesús Esteban</name></author><author><name sortKey="G Mez L Pez, Luis Ignacio" sort="G Mez L Pez, Luis Ignacio" uniqKey="G Mez L Pez L" first="Luis Ignacio" last="G Mez-L Pez">Luis Ignacio G Mez-L Pez</name></author><author><name sortKey="Gil, Angel" sort="Gil, Angel" uniqKey="Gil A" first="Angel" last="Gil">Angel Gil</name></author></titleStmt><publicationStmt><idno type="wicri:source">PubMed</idno><date when="2003">2003</date><idno type="RBID">pubmed:12922082</idno><idno type="pmid">12922082</idno><idno type="doi">10.1016/s0264-410x(03)00425-0</idno><idno type="wicri:Area/Main/Corpus">00638</idno><idno type="wicri:explorRef" wicri:stream="Main" wicri:step="Corpus" wicri:corpus="PubMed">00638</idno><idno type="wicri:Area/Main/Curation">000638</idno><idno type="wicri:explorRef" wicri:stream="Main" wicri:step="Curation">000638</idno><idno type="wicri:Area/Main/Exploration">000638</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en">Influenza coverages in Spain and vaccination-related factors in the subgroup aged 50-64 years.</title><author><name sortKey="Jimenez, Rodrigo" sort="Jimenez, Rodrigo" uniqKey="Jimenez R" first="Rodrigo" last="Jiménez">Rodrigo Jiménez</name><affiliation wicri:level="2"><nlm:affiliation>Unidad de Docencia e Investigación en Medicina Preventiva y Salud Pública, Facultad de Ciencias de la Salud, Universidad Rey Juan Carlos, Avenida de Atenas S/N, Alcorcón, 28402 Madrid, Spain. rjimenezg@cs.urjc.es</nlm:affiliation><country xml:lang="fr">Espagne</country><wicri:regionArea>Unidad de Docencia e Investigación en Medicina Preventiva y Salud Pública, Facultad de Ciencias de la Salud, Universidad Rey Juan Carlos, Avenida de Atenas S/N, Alcorcón, 28402 Madrid</wicri:regionArea><placeName><region nuts="2" type="communauté">Communauté de Madrid</region></placeName></affiliation></author><author><name sortKey="Larrauri, Amparo" sort="Larrauri, Amparo" uniqKey="Larrauri A" first="Amparo" last="Larrauri">Amparo Larrauri</name></author><author><name sortKey="Carrasco, Pilar" sort="Carrasco, Pilar" uniqKey="Carrasco P" first="Pilar" last="Carrasco">Pilar Carrasco</name></author><author><name sortKey="Esteban, Jesus" sort="Esteban, Jesus" uniqKey="Esteban J" first="Jesús" last="Esteban">Jesús Esteban</name></author><author><name sortKey="G Mez L Pez, Luis Ignacio" sort="G Mez L Pez, Luis Ignacio" uniqKey="G Mez L Pez L" first="Luis Ignacio" last="G Mez-L Pez">Luis Ignacio G Mez-L Pez</name></author><author><name sortKey="Gil, Angel" sort="Gil, Angel" uniqKey="Gil A" first="Angel" last="Gil">Angel Gil</name></author></analytic><series><title level="j">Vaccine</title><idno type="ISSN">0264-410X</idno><imprint><date when="2003" type="published">2003</date></imprint></series></biblStruct></sourceDesc></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Adolescent (MeSH)</term><term>Adult (MeSH)</term><term>Age Factors (MeSH)</term><term>Analysis of Variance (MeSH)</term><term>Cross-Sectional Studies (MeSH)</term><term>Female (MeSH)</term><term>Health Status (MeSH)</term><term>Humans (MeSH)</term><term>Influenza, Human (complications)</term><term>Influenza, Human (epidemiology)</term><term>Influenza, Human (prevention & control)</term><term>Life Style (MeSH)</term><term>Male (MeSH)</term><term>Middle Aged (MeSH)</term><term>Odds Ratio (MeSH)</term><term>Socioeconomic Factors (MeSH)</term><term>Spain (epidemiology)</term><term>Vaccination (statistics & numerical data)</term></keywords><keywords scheme="KwdFr" xml:lang="fr"><term>Adolescent (MeSH)</term><term>Adulte (MeSH)</term><term>Adulte d'âge moyen (MeSH)</term><term>Analyse de variance (MeSH)</term><term>Espagne (épidémiologie)</term><term>Facteurs socioéconomiques (MeSH)</term><term>Facteurs âges (MeSH)</term><term>Femelle (MeSH)</term><term>Grippe humaine (complications)</term><term>Grippe humaine (prévention et contrôle)</term><term>Grippe humaine (épidémiologie)</term><term>Humains (MeSH)</term><term>Mode de vie (MeSH)</term><term>Mâle (MeSH)</term><term>Odds ratio (MeSH)</term><term>Vaccination (statistiques et données numériques)</term><term>État de santé (MeSH)</term><term>Études transversales (MeSH)</term></keywords><keywords scheme="MESH" type="geographic" qualifier="epidemiology" xml:lang="en"><term>Spain</term></keywords><keywords scheme="MESH" qualifier="complications" xml:lang="en"><term>Influenza, Human</term></keywords><keywords scheme="MESH" qualifier="epidemiology" xml:lang="en"><term>Influenza, Human</term></keywords><keywords scheme="MESH" qualifier="prevention & control" xml:lang="en"><term>Influenza, Human</term></keywords><keywords scheme="MESH" qualifier="prévention et contrôle" xml:lang="fr"><term>Grippe humaine</term></keywords><keywords scheme="MESH" qualifier="statistics & numerical data" xml:lang="en"><term>Vaccination</term></keywords><keywords scheme="MESH" qualifier="statistiques et données numériques" xml:lang="fr"><term>Vaccination</term></keywords><keywords scheme="MESH" qualifier="épidémiologie" xml:lang="fr"><term>Espagne</term><term>Grippe humaine</term></keywords><keywords scheme="MESH" xml:lang="en"><term>Adolescent</term><term>Adult</term><term>Age Factors</term><term>Analysis of Variance</term><term>Cross-Sectional Studies</term><term>Female</term><term>Health Status</term><term>Humans</term><term>Life Style</term><term>Male</term><term>Middle Aged</term><term>Odds Ratio</term><term>Socioeconomic Factors</term></keywords><keywords scheme="MESH" xml:lang="fr"><term>Adolescent</term><term>Adulte</term><term>Adulte d'âge moyen</term><term>Analyse de variance</term><term>Facteurs socioéconomiques</term><term>Facteurs âges</term><term>Femelle</term><term>Humains</term><term>Mode de vie</term><term>Mâle</term><term>Odds ratio</term><term>État de santé</term><term>Études transversales</term></keywords><keywords scheme="Wicri" type="geographic" xml:lang="fr"><term>Espagne</term></keywords></textClass></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">This study sought to describe influenza vaccination coverages for different Spanish population subgroups, stressing the analysis of vaccination-related factors in subjects aged 50-64 years and estimating the possible beneficial effect of extending universal vaccination to this age group. A total of 6,400 surveys, targeting subjects over the age of 16 years and drawn from the 1997 Spanish National Health Survey, were used for study purposes. Influenza coverage was observed to rise significantly with age, and the reason cited by most subjects for seeking vaccination was medical indication. Coverage of the 50-64 age group was 21.6% (95% CI 19.4-23.8) and the variables associated with a greater probability of being vaccination were: residence in towns or cities with <10,000 inhabitants (OR 1.45); monthly income of less than 600 (OR 1.71); and presence of associated chronic disease (OR 3.07.) It is estimated that in Spain, 524,514 (40.7%) persons aged 50-64 years with associated chronic disease receive and 764,218 persons aged 50-64 years with associated chronic disease do not receive influenza vaccine. We conclude that the extremely high number of subjects in the 50-64 age range susceptible to influenza-related complications each year constitutes good grounds for universal vaccination being extended to said age group.</div></front></TEI><pubmed><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">12922082</PMID><DateCompleted><Year>2004</Year><Month>03</Month><Day>25</Day></DateCompleted><DateRevised><Year>2019</Year><Month>07</Month><Day>28</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Print">0264-410X</ISSN><JournalIssue CitedMedium="Print"><Volume>21</Volume><Issue>25-26</Issue><PubDate><Year>2003</Year><Month>Sep</Month><Day>08</Day></PubDate></JournalIssue><Title>Vaccine</Title><ISOAbbreviation>Vaccine</ISOAbbreviation></Journal><ArticleTitle>Influenza coverages in Spain and vaccination-related factors in the subgroup aged 50-64 years.</ArticleTitle><Pagination><MedlinePgn>3550-5</MedlinePgn></Pagination><Abstract><AbstractText>This study sought to describe influenza vaccination coverages for different Spanish population subgroups, stressing the analysis of vaccination-related factors in subjects aged 50-64 years and estimating the possible beneficial effect of extending universal vaccination to this age group. A total of 6,400 surveys, targeting subjects over the age of 16 years and drawn from the 1997 Spanish National Health Survey, were used for study purposes. Influenza coverage was observed to rise significantly with age, and the reason cited by most subjects for seeking vaccination was medical indication. Coverage of the 50-64 age group was 21.6% (95% CI 19.4-23.8) and the variables associated with a greater probability of being vaccination were: residence in towns or cities with <10,000 inhabitants (OR 1.45); monthly income of less than 600 (OR 1.71); and presence of associated chronic disease (OR 3.07.) It is estimated that in Spain, 524,514 (40.7%) persons aged 50-64 years with associated chronic disease receive and 764,218 persons aged 50-64 years with associated chronic disease do not receive influenza vaccine. We conclude that the extremely high number of subjects in the 50-64 age range susceptible to influenza-related complications each year constitutes good grounds for universal vaccination being extended to said age group.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Jiménez</LastName><ForeName>Rodrigo</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Unidad de Docencia e Investigación en Medicina Preventiva y Salud Pública, Facultad de Ciencias de la Salud, Universidad Rey Juan Carlos, Avenida de Atenas S/N, Alcorcón, 28402 Madrid, Spain. rjimenezg@cs.urjc.es</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Larrauri</LastName><ForeName>Amparo</ForeName><Initials>A</Initials></Author><Author ValidYN="Y"><LastName>Carrasco</LastName><ForeName>Pilar</ForeName><Initials>P</Initials></Author><Author ValidYN="Y"><LastName>Esteban</LastName><ForeName>Jesús</ForeName><Initials>J</Initials></Author><Author ValidYN="Y"><LastName>Gómez-López</LastName><ForeName>Luis Ignacio</ForeName><Initials>LI</Initials></Author><Author ValidYN="Y"><LastName>Gil</LastName><ForeName>Angel</ForeName><Initials>A</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>Netherlands</Country><MedlineTA>Vaccine</MedlineTA><NlmUniqueID>8406899</NlmUniqueID><ISSNLinking>0264-410X</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000293" MajorTopicYN="N">Adolescent</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000367" MajorTopicYN="N">Age Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000704" MajorTopicYN="N">Analysis of Variance</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003430" MajorTopicYN="N">Cross-Sectional Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006304" MajorTopicYN="N">Health Status</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007251" MajorTopicYN="N">Influenza, Human</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName><QualifierName UI="Q000453" MajorTopicYN="Y">epidemiology</QualifierName><QualifierName UI="Q000517" MajorTopicYN="Y">prevention & control</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008019" MajorTopicYN="N">Life Style</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016017" MajorTopicYN="N">Odds Ratio</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012959" MajorTopicYN="N">Socioeconomic Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D013030" MajorTopicYN="N" Type="Geographic">Spain</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D014611" MajorTopicYN="N">Vaccination</DescriptorName><QualifierName UI="Q000706" MajorTopicYN="Y">statistics & numerical data</QualifierName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2003</Year><Month>8</Month><Day>19</Day><Hour>5</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2004</Year><Month>3</Month><Day>26</Day><Hour>5</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2003</Year><Month>8</Month><Day>19</Day><Hour>5</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">12922082</ArticleId><ArticleId IdType="pii">S0264410X03004250</ArticleId><ArticleId IdType="doi">10.1016/s0264-410x(03)00425-0</ArticleId></ArticleIdList></PubmedData></pubmed><affiliations><list><country><li>Espagne</li></country><region><li>Communauté de Madrid</li></region></list><tree><noCountry><name sortKey="Carrasco, Pilar" sort="Carrasco, Pilar" uniqKey="Carrasco P" first="Pilar" last="Carrasco">Pilar Carrasco</name><name sortKey="Esteban, Jesus" sort="Esteban, Jesus" uniqKey="Esteban J" first="Jesús" last="Esteban">Jesús Esteban</name><name sortKey="G Mez L Pez, Luis Ignacio" sort="G Mez L Pez, Luis Ignacio" uniqKey="G Mez L Pez L" first="Luis Ignacio" last="G Mez-L Pez">Luis Ignacio G Mez-L Pez</name><name sortKey="Gil, Angel" sort="Gil, Angel" uniqKey="Gil A" first="Angel" last="Gil">Angel Gil</name><name sortKey="Larrauri, Amparo" sort="Larrauri, Amparo" uniqKey="Larrauri A" first="Amparo" last="Larrauri">Amparo Larrauri</name></noCountry><country name="Espagne"><region name="Communauté de Madrid"><name sortKey="Jimenez, Rodrigo" sort="Jimenez, Rodrigo" uniqKey="Jimenez R" first="Rodrigo" last="Jiménez">Rodrigo Jiménez</name></region></country></tree></affiliations></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Sante/explor/GrippeEspagneV1/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000642 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 000642 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Sante
|area= GrippeEspagneV1
|flux= Main
|étape= Exploration
|type= RBID
|clé= pubmed:12922082
|texte= Influenza coverages in Spain and vaccination-related factors in the subgroup aged 50-64 years.
}}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/RBID.i -Sk "pubmed:12922082" \
| HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd \
| NlmPubMed2Wicri -a GrippeEspagneV1
| This area was generated with Dilib version V0.6.37. |  |